Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Wu H, Diao J, Li X, Yue D, He G, Jiang X, et al
The study provides a detailed mechanistic insight into the interplay between metabolic reprogramming, protein stability, and drug response in the context of obesity and cancer
Effect of food consumption on the pharmacokinetics, safety, and tolerability of once-daily orally administered orforglipron (LY3502970), a non-peptide GLP-1 receptor agonist
We previously showed that the stimulation of FAO cells derived from rat hepatoma with different doses of insulin led to selective responses with different insulin sensitivities including the regulation of induced and basal insulin stimulation across multiple omics 24,30
Peptides that works as an agonist activate the same cell receptors as the bodys natural hormones, including GLP-1 and other similar ones
For the efficacy-evaluable population, the group of patients treated with ALC showed a significantly greater reduction in pain, compared to the placebo group
US$ 28.92
US$ 27.41
US$ 29.81
